Treatment for stimulant use is built differently from treatment for opioids or alcohol, and one fact explains why. There currently are no Food and Drug Administration-approved medications for stimulant use disorders [1].
That is not a gap the reader should paper over with hope. It means the behavioral side is not the supporting act here; it is the treatment. Which therapy, at which level of care, and for how long are therefore the questions worth asking on the first call.
This page covers when treatment helps, what the assessment looks at, whether detox comes first, what each level of care involves, which therapies have evidence behind them, and how coverage works. Our overview of Vyvanse and its effects covers the drug itself, and our page on the Vyvanse withdrawal timeline covers what stopping produces.
When Vyvanse use becomes something treatment can help with
The line is not a quantity, and for a prescription stimulant it is rarely a clean one.
Vyvanse is a brand of lisdexamfetamine, and the federal drug information states plainly that it is habit-forming [2]. Someone can hold a valid prescription and still be in trouble with it. Both things are true at once, which is why this page is careful not to tell anybody to stop a medication a prescriber put them on.
What treatment addresses is the pattern rather than the pill. Escalating past what was prescribed. Getting it from somewhere other than a pharmacy. Losing time to obtaining it, using it and recovering from it. Attempts to cut down that do not hold. A clinician makes that call, not a web page and not a symptom list.
One practical marker is worth naming, because people use it as a test and it is a poor one. Stopping suddenly after overusing lisdexamfetamine can produce severe depression and extreme tiredness [2]. Finding that out by experiment is not an assessment. Our page on withdrawal symptoms covers what stopping tends to produce.
If depression after stopping turns to thoughts of suicide, call or text 988. If someone is unresponsive or has trouble breathing, call 911.
Assessment: what a clinician looks for before recommending a level of care
The assessment is longer than people expect, and most of it is not about the drug.
Expect the use history first. Which form, how much, how long, how recently, and whether it started with a prescription. Expect a question about how it is being taken, because route changes the picture.
Expect a mental health history, and expect it to matter more here than it does for some other substances. Federal guidance on stimulant use disorders devotes a full chapter to how stimulants act on the brain and behavior and to what assessment and diagnosis involve [3]. Separating a mood problem that predates the drug from one the drug produced is a large part of what that hour is for.
Expect questions about physical health, other substances, and the shape of an ordinary week: work, sleep, who is at home, what happens on a bad day. The output is a recommended level of care and a first plan. Our pages on what the treatment process is like and how admission works cover what follows.
Does Vyvanse need medical detox first?
Sometimes, and the reason is usually psychiatric rather than medical.
Federal treatment guidance describes stimulant withdrawal as a syndrome that usually does not involve medical danger or intense patient discomfort [4]. That is a real difference from alcohol or sedative withdrawal, and it is why a stimulant detox is not built the same way.
The same chapter limits its own sentence in the paragraph directly after it. An often overlooked but potentially lethal medical danger during stimulant withdrawal is the risk of a profound dysphoria, meaning depression and negative thoughts and feelings, that may include suicidal ideas or attempts [4]. Amphetamine users in particular should be monitored closely during detoxification for signs of suicidality and treated for depression if appropriate [4]. Lisdexamfetamine is an amphetamine, so that instruction is written about this drug.
If depression after stopping turns to thoughts of suicide, call or text 988. If someone is unresponsive or has trouble breathing, call 911.
What it is built around is the drop that follows. Severe depression and extreme tiredness can develop after suddenly stopping lisdexamfetamine following overuse [2], and somebody watching for that is worth more here than a cardiac monitor.
There is also a sequencing point that belongs to a prescriber. The instruction in the federal drug information is not to suddenly stop taking lisdexamfetamine without talking to a doctor, especially after overusing it [2]. A doctor will probably decrease the dose gradually and monitor carefully during that time [2]. This page publishes no schedule of its own for that, because the schedule belongs to the person writing it.
If depression after stopping turns to thoughts of suicide, call or text 988. If someone is unresponsive or has trouble breathing, call 911.
Medical detox is a level of care rather than a course of treatment, and what follows it is what the evidence base is actually about.
Where treatment for stimulant use can start
The Recovery Village Umatilla is our campus in Umatilla, Florida. It provides medical detox, residential and inpatient treatment, inpatient mental health treatment, a partial hospitalization program, outpatient care and aftercare planning. The campus says it welcomes in- and out-of-state clients and tailors its services to accommodate military veterans, members of the LGBTQ+ community and the elderly.
See treatment options in Florida
Verify your insurance
The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.
Residential treatment for Vyvanse use, and who it suits
Residential care means living at the program while the day is built around clinical work, and it suits a narrower group than the internet implies.
It fits where the home setting is where use happens, where a lighter level has already been tried and did not hold, or where a mental health picture needs daily eyes on it rather than a weekly appointment.
It is not a stronger version of the same thing. It is a different exposure: the environment comes out of the equation for a period, which buys time to start the behavioral work when concentration and mood are at their worst.
Ask what follows it before agreeing to it. Residential care that ends with no named next appointment gives the hardest weeks back to the person with nothing around them. Our page on residential and inpatient care sets out what the days involve.
PHP and IOP for Vyvanse use
Between residential care and a weekly appointment sit two tiers, and the difference between them is hours rather than philosophy.
The American Society of Addiction Medicine defines intensive outpatient treatment as 9 hours of treatment a week for adults [5], generally spread over 3 to 5 days, though some programs provide fewer hours [5]. TIP 47’s consensus panel recommends a range of 6 to 30 hours, based on client needs [5]. A partial hospitalization program runs closer to full clinical hours while the person sleeps at home or in supported housing.
Intensive outpatient programs serve three roles rather than one: an entry point into substance abuse treatment, a step-down from a higher level, and a step-up for people for whom a standard outpatient program has not worked [5]. That third role is the one that matters if a lighter attempt has already failed.
Those levels are points on a continuum rather than separate boxes [5]. Our explainers on levels of care and outpatient rehab set out what each tier involves week to week.
Therapies with the strongest evidence for this substance
This is the section that matters most on a stimulant page, because the therapy is not an adjunct to a medication here.
Contingency management carries the most evidence. Federal guidance describes it as a well-known behavioral intervention designed to increase desired behaviors by providing immediate reinforcing consequences, and says these interventions have by far the greatest amount of empirical support for their efficacy in promoting therapeutic behavioral change among people who use stimulants [1]. In plain terms, it rewards verified progress promptly rather than at the end.
Cognitive behavioral therapy is the one most people have heard of, and the honest position is more qualified. Despite increased research, its effectiveness is still unclear, although CBT in combination with contingency management may be especially helpful [1]. That hedge belongs on the page; dropping it would oversell the most familiar name in the field.
Relapse prevention is the CBT variant with the most concrete description. It teaches patients strategies, skills and lifestyle adaptations to help them change their thoughts and behaviors [1]. That is the work the residential or outpatient hours are spent on.
Our pages on therapy approaches used in treatment and cognitive behavioral therapy explain what those sessions involve.
Medication options, where they exist
The short answer is that for the stimulant use itself, they do not.
There currently are no Food and Drug Administration-approved medications for stimulant use disorders [1]. Any page that implies a prescription can do for Vyvanse what buprenorphine does for opioids is selling something the evidence does not support.
That absence is precisely why the behavioral interventions above carry the weight they do [1]. It is also why a program’s answer to “what are the therapy hours and who runs them” tells you more here than its answer about medication.
Medication still appears in two other places. One is the gradual reduction a prescriber manages when someone is coming off [2]. The other is treatment of a co-occurring condition, which is a separate prescription for a separate diagnosis. Our page on medication-assisted treatment explains where that model does and does not apply.
Co-occurring mental health conditions and why they change the plan
A mental health condition alongside stimulant use changes the level of care, the therapy and the sequence, which is why the assessment asks about it so early.
The reason is partly pharmacological. Federal guidance on stimulant use disorders sets out at chapter length how stimulants act on the brain and behavior, and treats assessment and diagnosis as inseparable from that [3]. A mood or attention problem that came before the drug and one the drug produced need telling apart before either is treated.
It is also practical. Severe depression after stopping is a documented risk [2], and someone already carrying a mood disorder is meeting that on top of it rather than instead of it.
If depression after stopping turns to thoughts of suicide, call or text 988. If someone is unresponsive or has trouble breathing, call 911.
Where both are in the picture, ask whether the program holds them on one plan or hands them to two separate services.
Paying for Vyvanse treatment and verifying benefits
Coverage is decided per plan and per level of care, and the general rules only tell you the shape of the answer.
Parity law is the main one. A plan that covers substance use disorder benefits may not apply tighter financial requirements or treatment limits to that care than it applies to medical and surgical benefits [6]. Those rules reach limits such as prior authorization [6]. Parity has a scope worth knowing. It applies to non-federal governmental plans with more than 50 employees, to private employer group plans with more than 50 employees, and to individual-market coverage [6]. Small-employer group plans are generally outside it, though non-grandfathered small-group and individual plans must cover mental health and substance use disorder services as an essential health benefit under the Affordable Care Act [6].
Two boundaries follow from that. Parity does not by itself oblige a plan to cover this care [6]. And prior authorization is a limit parity governs rather than one it removes [6], so ask whether a step up or down needs a fresh approval.
A verification call produces the numbers this page deliberately does not quote: network status, deductible, out-of-pocket maximum and which levels are approved. Our pages on insurance coverage for rehab, what treatment costs and how long treatment takes explain the terms before you make it, and our treatment centers lists the campuses we run.
Frequently Asked Questions
Do I need inpatient treatment for Vyvanse use? Not necessarily, and an assessment decides it rather than a preference. Residential care tends to fit where home is where use happens, where a lighter level has already been tried, or where a mental health picture needs daily review. Intensive outpatient and partial hospitalization sit below it, and those levels are points on a continuum rather than separate boxes.
Is there a medication for Vyvanse addiction? No. There currently are no Food and Drug Administration-approved medications for stimulant use disorders, which is why the behavioral interventions carry the weight. Medication still appears in two other places: the gradual reduction a prescriber manages when someone is coming off, and treatment of a co-occurring condition, which is a separate diagnosis with its own prescription.
How long does Vyvanse treatment take? Longer than stopping, and the length follows the clinical picture rather than a calendar. The American Society of Addiction Medicine defines intensive outpatient treatment as 9 hours of treatment a week for adults, generally over 3 to 5 days, inside a recommended range of 6 to 30 hours based on client needs. Care steps down as stability returns.
Will insurance cover it? Often, and parity rules shape the terms. A plan that covers substance use disorder benefits may not put tighter financial requirements or treatment limits on that care than on medical and surgical care, including limits such as prior authorization. The rules do not by themselves oblige a plan to cover the care. Prior authorization is a limit parity governs rather than one it removes, so ask whether a step up or down needs a fresh approval.
What happens on the first call? Expect the call itself first, with a pre-admissions assessment, and the cost and insurance conversation next. That is the order our own guide to getting into rehab sets out. Expect questions about how much, how long, how recently, whether it began as a prescription, and what has been tried before. Expect mental health questions too. Ask what the therapy hours are and who runs them, because on a stimulant page that answer matters more than the medication one.
Sources
- Substance Abuse and Mental Health Services Administration. (2021). Treatment for Stimulant Use Disorders — Chapter 4, Approaches to Treatment. Treatment Improvement Protocol (TIP) Series No. 33, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK576540/
- MedlinePlus. Lisdexamfetamine. U.S. National Library of Medicine, National Institutes of Health. https://medlineplus.gov/druginfo/meds/a607047.html
- Substance Abuse and Mental Health Services Administration. (2021). Treatment for Stimulant Use Disorders — Chapter 2, How Stimulants Affect the Brain and Behavior. Treatment Improvement Protocol (TIP) Series No. 33, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK576548/
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment — Chapter 4, Physical Detoxification Services for Withdrawal From Specific Substances. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64116/
- Center for Substance Abuse Treatment. (2006). Substance Abuse: Clinical Issues in Intensive Outpatient Treatment — Chapter 3, Intensive Outpatient Treatment and the Continuum of Care. Treatment Improvement Protocol (TIP) Series No. 47, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64088/
- Centers for Medicare & Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
